4-1002713-GCCC-GCC
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000203.5(IDUA):c.1190-10delC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00392 in 1,358,110 control chromosomes in the GnomAD database, including 112 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000203.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0151 AC: 2254AN: 149676Hom.: 49 Cov.: 29
GnomAD3 exomes AF: 0.00548 AC: 401AN: 73188Hom.: 6 AF XY: 0.00417 AC XY: 173AN XY: 41468
GnomAD4 exome AF: 0.00253 AC: 3062AN: 1208336Hom.: 61 Cov.: 24 AF XY: 0.00221 AC XY: 1322AN XY: 598660
GnomAD4 genome AF: 0.0151 AC: 2265AN: 149774Hom.: 51 Cov.: 29 AF XY: 0.0144 AC XY: 1056AN XY: 73100
ClinVar
Submissions by phenotype
not specified Benign:2
- -
Variant summary: IDUA c.1190-10delC alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0055 in 73188 control chromosomes in the gnomAD database, including 6 homozygotes. The observed variant frequency is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in IDUA causing Mucopolysaccharidosis Type 1 phenotype (0.0027), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1190-10delC in individuals affected with Mucopolysaccharidosis Type 1 and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Mucopolysaccharidosis type 1 Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at